These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33909769)

  • 1. Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death.
    Xu CR; Fang QJ
    Arq Bras Cardiol; 2021 Mar; 116(3):415-422. PubMed ID: 33909769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA-XIST protects the hypoxia-induced cardiomyocyte injury through regulating the miR-125b-hexokianse 2 axis.
    Fan JL; Zhu TT; Xue ZY; Ren WQ; Guo JQ; Zhao HY; Zhang SL
    In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):349-357. PubMed ID: 32415544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of
    Zhang Y; Liu G; Gao X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28894025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-125b protects hyperglycemia-induced, human retinal pigment epithelial cells (RPE) from death by targeting hexokinase 2.
    Huang JF; Cheng KP; Wang SJ; Huang HM; Wang ZJ
    Int J Clin Exp Pathol; 2018; 11(6):3111-3118. PubMed ID: 31938439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influences of the lncRNA TUG1-miRNA-34a-5p network on fibroblast-like synoviocytes (FLSs) dysfunction in rheumatoid arthritis through targeting the lactate dehydrogenase A (LDHA).
    Zhang M; Lu N; Guo XY; Li HJ; Guo Y; Lu L
    J Clin Lab Anal; 2021 Sep; 35(9):e23969. PubMed ID: 34403518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA OIP5-AS1 Overexpression Promotes Viability and Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting MicroRNA-34a/SIRT1 Axis in Diabetic Cardiomyopathy.
    Sun H; Wang C; Zhou Y; Cheng X
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2017-2027. PubMed ID: 33380310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-34a suppresses osteoblast differentiation through glycolysis inhibition by targeting lactate dehydrogenase-A (LDHA).
    Hong M; Zhang XB; Xiang F; Fei X; Ouyang XL; Peng XC
    In Vitro Cell Dev Biol Anim; 2020 Jun; 56(6):480-487. PubMed ID: 32719987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a regulates high glucose-induced apoptosis in H9c2 cardiomyocytes.
    Zhao F; Li B; Wei YZ; Zhou B; Wang H; Chen M; Gan XD; Wang ZH; Xiong SX
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):834-839. PubMed ID: 24337844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
    Ni T; Lin N; Lu W; Sun Z; Lin H; Chi J; Guo H
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):291-301. PubMed ID: 32212062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atractylodes-I Overcomes the Oxidative Stress-induced Colonic Mucosal Epithelial Cells Dysfunction to Prevent Irritable Bowel Syndrome
    Xu R; Liu X; Tian M; Chen D
    Curr Mol Med; 2023; 23(8):825-833. PubMed ID: 35959614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside-IV protects H9C2(2-1) cardiomyocytes from high glucose-induced injury via miR-34a-mediated autophagy pathway.
    Zhu Y; Qian X; Li J; Lin X; Luo J; Huang J; Jin Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4172-4181. PubMed ID: 31713440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danlou tablet inhibits high-glucose-induced cardiomyocyte apoptosis via the miR-34a-SIRT1 axis.
    Chen R; Chen H; Yang Z; Zhu L; Bei Y; Chen W; Qiu Y
    Heliyon; 2023 Mar; 9(3):e14479. PubMed ID: 36950610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of the hypoxia-induced miR-34a protects cardiomyocytes through maintenance of glucose metabolism.
    Wang ZC; Wang ZZ; Ma HJ; Wang CC; Wang HT
    Biochem Biophys Res Commun; 2018 Apr; 498(3):375-381. PubMed ID: 28709867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1.
    Li P; Xu Y; Wang B; Huang J; Li Q
    J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-34a inhibitor protects mesenchymal stem cells from hyperglycaemic injury through the activation of the SIRT1/FoxO3a autophagy pathway.
    Zhang F; Gao F; Wang K; Liu X; Zhang Z
    Stem Cell Res Ther; 2021 Feb; 12(1):115. PubMed ID: 33546760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells.
    Fomison-Nurse I; Saw EEL; Gandhi S; Munasinghe PE; Van Hout I; Williams MJA; Galvin I; Bunton R; Davis P; Cameron V; Katare R
    Cell Death Differ; 2018 Jul; 25(7):1336-1349. PubMed ID: 29302057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy.
    Gao L; Wang X; Guo S; Xiao L; Liang C; Wang Z; Li Y; Liu Y; Yao R; Liu Y; Zhang Y
    J Cell Physiol; 2019 Apr; 234(4):4944-4958. PubMed ID: 30216438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA PVT1 facilitates high glucose-induced cardiomyocyte death through the miR-23a-3p/CASP10 axis.
    Yu FR; Xia YW; Wang SB; Xiao LH
    Cell Biol Int; 2021 Jan; 45(1):154-163. PubMed ID: 33049089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b.
    Aghamajidi A; Ousati Ashtiani Z; Mohsenzadegan M; Tajik N; Ghafoori Yazdi M; Sharifi L; Nowroozi MR
    Iran J Allergy Asthma Immunol; 2022 Oct; 21(5):561-573. PubMed ID: 36341564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
    Hui L; Zhang J; Guo X
    Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.